InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: ArchieK post# 331154

Monday, 07/29/2019 2:49:07 PM

Monday, July 29, 2019 2:49:07 PM

Post# of 345969
True, though all Peregrine Pharmaceuticals ...now Avid Bioservices shareholders should expect to have BOD members that maximize share price via the business model

Avid BODs elected to place PS Targeting IP assets / biomarker data exosomes etc etc into others hands

It may be time for all those shareholder letters to also be sent to Dr Mackey and as an independent Director she would have the fiduciary duty to take proper steps in verifying what was completed in the past ....(because future buyout depends on it) and ask her peers

" ..with the contracts and profitability to Avid, why would we elect to pick up breadcrumbs vs splitting off the IP side of the house and make Peregrine the subsidiary with separate stock symbol and all goes as planned with Avid CDMO till they maximize a deal with the IP"

"...I know Biomarkers and I am on the Board at Poseida where their IP may be threatened by PS Targeting IP research/ data etc ....Novartis has much invested in CAR-T and Poseida could utilize the PS Targeting IP and ..."

My question to Dr Mackey..

Ask the BOD if there are any clauses where if Oncologie Inc withers away the IP ...do we Avid BOD have rights to pull it back away from Oncologie Inc ?

If not....this is as bad as not placing full criminal blame upon CSM for sabotage

For those that do not want to maximize shareholder value....Why not

There is a reason why Dr Mackey is here and I am not convinced fully just yet
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News